ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Electronic Health Record"

  • Abstract Number: 784 • 2015 ACR/ARHP Annual Meeting

    Electronic Health Record (EHR) As a Powerful Tool to Establish Clinical Research Lupus Cohorts

    Srilatha Kothandaraman1, Frederick Ramsey2, David Fleece3, Aaron Sorenson2, Lai Ping4, Srikanth Mukkera1, King Goh1 and Roberto Caricchio5, 1Rheumatology, Temple University, Philadelphia, PA, 2Clinical Sciences, Temple University, Philadelphia, PA, 3Pediatrics, Temple University, Philadelphia, PA, 4Temple University, Philadelphia, PA, 5Medicine, Rheumatology, Temple University, Philadelphia, PA

    Background/Purpose: Enhancing a typical EHR through implementation and utilization of research-validated instruments is termed Electronic Data Capture (EDC). EDC is found to be more efficient…
  • Abstract Number: 1228 • 2015 ACR/ARHP Annual Meeting

    Estimating Under-Diagnosis of Rheumatoid Arthritis in Primary Care Data from the UK Clinical Practice Research Datalink

    Julian Gardiner1, Bowen Su1, Benjamin Ellis2 and Michael Soljak1, 1Department of Primary Care and Public Health, Imperial College London, London, United Kingdom, 2Arthritis Research UK, London, United Kingdom

    Background/Purpose: The prevalence of rheumatoid arthritis (RA) in primary care electronic health records (EHRs) is much lower than patient self-reports from population surveys, which may…
  • Abstract Number: 1994 • 2015 ACR/ARHP Annual Meeting

    Electronic Patient Reported Outcome Measures in Systemic Lupus Erythematosus : A Potential Disease Modifying Impact on the Management of Disease Activity Flares and Damage Accrual

    Yasser M. El Miedany1, Sami Bahlas2, Maha El Gaafary3, Sally Youssef4 and Ihab Ahmed5, 1Rheumatology, Darent Valley Hospital, Dartford, United Kingdom, 2Medicine, King Abdulaziz University, Jeddah, Saudi Arabia, 3Community, Environmental and Occupational Medicine, Ain Shams University, Abbassia, Egypt, 4Rheumatology and Rehabilitation Departmennt, Ain Shams University, Cairo, Egypt, 5Medicine, Cairo University, Cairo, Egypt

    Background/Purpose: Patient reported outcomes measures (PROMs) are changing the landscape in rheumatology care. Electronic PROMs (ePROMs) is a new patient-centric model of collaboration that fully…
  • Abstract Number: 2483 • 2015 ACR/ARHP Annual Meeting

    Adherence to 2011 American Academy of Ophthalmology Guidelines to Perform Objective Screening Tests for Detection of Antimalarial Retinal Toxicity Is Suboptimal

    Sarah Haserodt1, Chris Tonner2, Sara G. Murray3, Gabriela Schmajuk4 and Jinoos Yazdany5, 1Internal Medicine, California Pacific Medical Center, San Francisco, CA, 2Rheumatology, University of California, San Francisco, San Francisco, CA, 3Medicine, University of California, San Francisco, San Francisco, CA, 4Medicine/ Rheumatology, UCSF/ San Francisco VA, San Francisco, CA, 5University of California, San Francisco, San Francisco, CA

    Background/Purpose: American Academy of Ophthalmology (AAO) 2011 guidelines recommend that patients receiving hydroxychloroquine (HCQ) or chloroquine (CQ) undergo regular screening for retinal toxicity with 1…
  • Abstract Number: 2486 • 2015 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Quality Measures – Automated Display of Care Gaps and Capture of Physician Decision Making at the Clinic Visit

    Eric Newman1, Tarun Sharma2, Alicia Meadows2, Jason Brown3, Michael Rowe4 and Shelly Vezendy5, 1Department of Rheumatology, Geisinger Health System, Danville, PA, 2Rheumatology, Geisinger Health System, Danville, PA, 3Henry Hood Center for Clinical Research, Geisinger Health System, Danville, PA, 4Institute for Advanced Application, Geisinger Health System, Danville, PA, 5Division of Medicine, Geisinger Health System, Danville, PA

    Background/Purpose:  Rheumatoid Arthritis (RA) quality measures evaluate performance, and thus do not by themselves result in improvement.  The ideal system to improve quality would provide…
  • Abstract Number: 2494 • 2015 ACR/ARHP Annual Meeting

    An Electronic Safety Dashboard for Rheumatology Clinics

    Mary Margaretten1, Laura Trupin1, Sarah Goglin2 and Jinoos Yazdany1, 1University of California, San Francisco, San Francisco, CA, 2Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Patient safety problems are increasing in rheumatology given the growing use of high-risk immunosuppressive drugs. Electronic health record "dashboards" have been utilized in research…
  • Abstract Number: 2697 • 2015 ACR/ARHP Annual Meeting

    Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia

    Jayanth Doss1, Huan Mo2, Leslie J. Crofford1 and Joshua C. Denny2, 1Rheumatology, Vanderbilt University School of Medicine, Nashville, TN, 2Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN

    Background/Purpose: The differences between seronegative and seropositive rheumatoid arthritis (RA) have not been widely reported. We performed an electronic health record (EHR)-based phenome-wide association study…
  • Abstract Number: 2076 • 2014 ACR/ARHP Annual Meeting

    Predictive Modeling of a Fibromyalgia Diagnosis: Increasing the Accuracy Using Real World Data

    Birol Emir1, Jack Mardekian1, Elizabeth T. Masters1, Andrew Clair1, Max Kuhn2 and Stuart L. Silverman3, 1Pfizer Inc, New York, NY, 2Pfizer Inc., Groton, CT, 3Cedars-Sinai Medical Center, UCLA Center of Excellence, Los Angeles, CA

    Background/Purpose: The number of symptoms and comorbidities associated with the chronic pain condition of fibromyalgia (FM) complicates its identification and diagnosis. Methods: This retrospective analysis…
  • Abstract Number: 1354 • 2014 ACR/ARHP Annual Meeting

    Improving the Measurement of Disease Activity for Patients with Rheumatoid Arthritis: Validation of an Electronic Version of the Routine Assessment of Patient Index Data (RAPID 3)

    Ruthie May Chua1, John Mecchella2,3 and Alicia Zbehlik4,5, 1Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Geisel School of Medicine at Dartmouth, Hanover, NH, 3Dartmouth Hitchcock Medical Center, Lebanon, NH, 4Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, 5The Geisel School of Medicine at Dartmouth, The Dartmouth Centers for Health and Aging, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH

    Background/Purpose Quantitative measures of disease activity are associated with improved outcomes for patients with rheumatoid arthritis (RA), but many rheumatologists continue to rely on non-quantitative…
  • Abstract Number: 1353 • 2014 ACR/ARHP Annual Meeting

    Integrating Collection of Rheumatoid Arthritis Disease Activity and Physical Function Scores into an Academic Rheumatology Practice to Improve Quality of Care

    Vladimir Chernitskiy1, Andre DeVito2, Naama Neeman2, Niraj Sehgal2, Jinoos Yazdany3 and Andrew J. Gross3, 1Rheumatology, University of California, San Francisco, San Francisco, CA, 2Medicine, University of California San Francisco, San Francisco, CA, 3Medicine, University of California, San Francisco, San Francisco, CA

    Background/Purpose: The default design of our institutions’ electronic health record (EHR)(Epic Systems) was not optimally structured to systematically collect quality metrics for rheumatic disease management…
  • Abstract Number: 1346 • 2014 ACR/ARHP Annual Meeting

    Leveraging Electronic Health Records to Improve Vaccination Rates for Patients with Rheumatoid Arthritis

    David W Baker1, Tiffany Brown1, Ji Young Lee1, Diana S Sandler2, David T Liss1, Amanda Ozanich1, Elizabeth Harsha Strong3, Alpa Patel1 and Eric M. Ruderman4, 1Northwestern University, Chicago, IL, 2Medicine/Rheumatology, Northwestern University, Chicago, IL, 3Rheumatology, Northwestern University, Chicago, IL, 4Div of Rheumatology, Northwestern University, Chicago, IL

    Background/Purpose: Vaccination rates among patients with rheumatoid arthritis (RA) remain low.  Improving these rates is important, as RA patients are inherently immunocompromised and frequently treated…
  • Abstract Number: 708 • 2014 ACR/ARHP Annual Meeting

    Determining Risk Factors That Increase Hospitalizations in Patients with Systemic Lupus Erythematosis

    Hareth M. Madhoun1, Wael N. Jarjour2, Peter J. Embi3, Erinn M. Hade4 and W Neal Roberts Jr5, 1Rheumatology/Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 3Biomedical Informatics & Internal Medicine, The Ohio State University, Columbus, OH, 4College of Medicine Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, OH, 5Dept of Internal Medicine, Division of Rheumatology, University of Louisville, Louisville, KY

    Background/Purpose Systemic lupus erythematosis (SLE) is a complex heterogeneous disease which can be associated with significant morbidity and mortality. Hospitalization and readmissions have garnered significant…
  • Abstract Number: 372 • 2014 ACR/ARHP Annual Meeting

    Diagnostic Accuracy and Associated Costs of Rheumatoid Factor Testing in Primary Care: A Population-Based Cohort Study in Spain

    Raashid Luqmani1, Klara Morsley2, Anne Miller3, Christopher J. Edwards4, M. Kassim Javaid5, Daniel Prieto-Alhambra6, Rafael Pinedo-Villanueva7,8, Manuel Medina Peralta9, Sebastian Calero Munoz9, Nigel Arden10,11, Francesc Fina-Aviles9 and Cyrus Cooper12, 1Oxford NIHR Musculoskeletal Biomedical Research Unit, Oxford, United Kingdom, 2Oxford University Hospitals NHS Trust, Nuffield Orthopaedic Centre, Oxford, United Kingdom, 3Rheumatology, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Trust, Oxford, United Kingdom, 4University Hospital Southampton, Southampton, United Kingdom, 5Rheumatology, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK, Oxford, United Kingdom, 6NIHR Musculoskeletal Biomedical Research Unit, Oxford, United Kingdom, 7NDORMS, University of Oxford, Oxford, United Kingdom, 8MRC Lifecourse Epidemiology Unit, Southampton, United Kingdom, 9Institut Català de la Salut, Barcelona, Spain, 10NIHR Musculoskeletal Biomedical Research Unit University of Oxford, Oxford, United Kingdom, 11University of Southampton, Southampton, United Kingdom, 12MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom

    Background/Purpose: To assess the sensitivity, specificity, and predictive values of rheumatoid factor (RF) as a test for rheumatoid arthritis (RA) in primary care, and to…
  • Abstract Number: 129 • 2013 ACR/ARHP Annual Meeting

    Identifying Predictors Of A Fibromyalgia Diagnosis: A Retrospective Electronic Medical Record Analysis

    Elizabeth T. Masters1, Jack Mardekian1, Andrew Clair1 and Stuart L. Silverman2, 1Pfizer Inc, New York, NY, 2Cedars-Sinai Medical Center, UCLA Center of Excellence, Los Angeles, CA

    Background/Purpose: Fibromyalgia (FM) is a chronic pain condition characterized by a constellation of symptoms and comorbidities. Consequently, FM diagnosis can be challenging and it often…
  • Abstract Number: 1918 • 2013 ACR/ARHP Annual Meeting

    Adoption Of New Electronic Medical Records May Inhibit Documentation Of Physician Quality Reporting System

    Minzi Chen, William E. Davis, Austin Fraser, Jerald M. Zakem, Eve Scopelitis, Kismet Collins, MD, Tamika A. Webb-Detiege and Robert Quinet, Rheumatology, Ochsner Medical Center, New Orleans, LA

    Background/Purpose:   Lower back pain (LBP) is a common complaint in the general population and accounts for 2.5% of all outpatient office visits. Critical assessment…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology